Let customers speak for us
-
Australian
Owned & Made -
Clinically Backed 100%
Natural Ingredients -
Support Gastrointestinal System Health
-
Vegan-friendly
Gluten free. Non GMO -
Support Hormonal Health
It’s Science That Puts You First
Every Gut + Hormone ingredient is scientifically proven to promote a diverse gut microbiome, balance female hormone health, support menstrual cycle regularity and enhance insulin sensitivity for weight management.
Meet our scientifically selected bioactives in Gut + Hormone
-
Myo-Inositol
Over 700+ clinical studies supporting metabolic and hormone benefits, reducing insulin resistance and lowering BMI.
-
Prebiotic Organic Kiwi Fruit Extract Actazin TM
Feeds and supports the growth of probiotic species, improves digestive health & enhances amino acid absorption.
-
Methylated Folate
Folate is essential for DNA synthesis and tissue repair, supporting neurotransmitter production, improving fertility and reducing menopause symptoms.
-
Unique IS-2 Probiotic
Over 20+ clinical studies supporting digestive health, immune health & healthy vaginal flora. This proven probiotic also reduces gastrointestinal symptoms including IBS and constipation, & enhances protein absorption.
-
Vitamin D3
Essential for healthy functioning of your microbiome, adequate vitamin D supports a healthy menstrual cycle and the release of antimicrobials to modulate the immune system.
Gut + Hormone is blend of plant-based compounds to naturally balance hormones and support metabolic health
Active Ingredients
We developed Gut + Hormone with a precise formulation of hormone balancing gut health essentials for you to thrive.
Active ingredients per serve
Myo-Inositol | 2000 mg |
Actazin® Kiwifruit powder (Actinidia deliciosa) | 250 mg |
Levomefolate Glucosamine (Quatrefolic®, (6S)-5-methyltetrahydrofolate) | 497 mcg |
Colecalciferol (Vitamin D3) | 25 mcg (1000 IU) |
Bacillus coagulans MTCC 5260 (UNIQUE IS-2® ) | 2 billion CFU |
Blended with natural antioxidant wildberry extracts and a FODMAP friendly dose of prebiotic inulin (less than 1 gram).
Does not contain: Animal products, gluten, dairy, artificial flavours or colours. Store below 30°C in a dry cool place.
TGA Listed and proudly Australian made in a quality assured facility Certified by the Australian Therapeutic Goods Administration.
Warnings: Vitamin and mineral supplements should not replace a balanced diet. Bacillus coagulans may affect the way some medicines work, including immunosuppressants. Consult your health professional before taking with other medicines. If symptoms persist, talk to your health professional. Contains sugars, sulfites, sugar alcohol (myo-inositol), and soya bean products. Not suitable for children.
Directions for Use
Add one sachet to 150 mls water or your beverage of choice. Mix before drinking.
Key Benefits
- Supports healthy hormonal balance during the reproductive cycle
- supports healthy reproductive hormones
- supports gastrointestinal system health
- supports menstrual cycle regularity
- supports healthy blood glucose levels
- supports gastrointestinal immune function
- supports immune system health
- supports healthy bowel function
Gut + Hormone
Ready for Balanced Hormones + a Microbiome + Metabolic Boost?
One sachet, once a day
-
Bioavailable methylated folate for enhanced absorption & DNA repair
-
Myo-Inositol for metabolic health and menstrual cycle regularity
-
Prebiotic + Probiotic to support a healthy microbiome & the production of postbiotics
-
1 sachet per day simply mix in water to create a
fertile gut
Meet our Scientifically Selected Ingredients
Formulated for gut microbiome support, balanced hormones, metabolic health, immune health & digestive support
Myo-Inositol
Myo-inositol is a nutrient involved in many cellular functions, including reproduction and metabolism.
Found in found in fruits, beans, grains, and nuts our body also makes a small amount of myo-inositol each day but increasing age, antibiotic use, caffeine, sugar and refined carbohydrate intake and insulin resistance all increase the need for myo-inositol.
Supplementing with myo-inositol has been shown to increase insulin sensitivity to support healthy blood glucose levels, reduce BMI and enhance metabolic health.
Myo-inositol promotes healthy hormone levels to support regular menstrual cycles, healthy ovarian function and insulin sensitivity.
Synbiotic Action
Activated Folate
Gut + Hormone is formulated with Quatrefolic®, the 4th generation active folate. Folate is a B vitamin essential for making and repairing DNA, protein metabolism and making red blood cells. Mutations in the MTHFR gene occur in approximately 1 in 3 people. This mutation may lower folate and other vitamins.
Folate deficiency (not getting adequate folate) is one of the most common vitamin deficiencies in Australia. As folate is a water-soluble B vitamin your body cannot store it.
Quatrefolic® supplementation allows 5-methyltetrahydrofolate to be immediately bioavailable for its biological action, increasing serum folate by up to 55% higher than folic acid. Folate is essential across the lifespan supporting a healthy menstrual cycle, pregnancy, and dampening vasomotor symptoms in menopause.
Plant Based Vitamin D
Adequate vitamin D supports a healthy menstrual cycle and a healthy gut microbiome.
This important vitamin regulates tight junctions in the gut, and we know
that a strong gut barrier means less inflammation.
Reducing inflammation
lowers prostaglandins and improves regulation of ovulation and your
menstrual cycle.
Adequate circulating levels of vitamin D have been shown to reduce menstrual pain, enhance fertility, and reduce menopausal symptoms.
As well as improving your gut health, Vitamin D supports the release of antimicrobials to modulate the immune system.
The Royal Australian and New Zealand College of Obstetricians and
Gynaecologists (RANZCOG) recommends that women without a
vitamin D deficiency should take 4001U of vitamin D3 daily.
Gut + Hormone delivers 1000IU of plant-based Vitamin D3 to
support your fertility and wellbeing.
Frequently Asked Questions
Can I incorporate multiple Fertile Gut products into my day?
range of science backed formulations into each day.
Microbiome Essentials is our intestinal repair and restore powerhouse while Cacao Latte delivers additional digestive, mood, sleep & microbiome benefits with it's synbiotic combination. Gut + Hormone supports gut health and is designed to regulate female reproductive & metabolic health from better periods, to optimal fertility & a smoother perimenopause.
How long until I benefit from my daily Fertile Gut goodness?
Depending on the starting health of your microbiome you may feel benefits of these positive shifts within a few weeks to 2 to 3 months. Clinical studies that support the benefits of our formulations have shown significant benefits within this time frame.
Consistent use is key to unlocking the full potential of your gut microbiome. The longer you use Fertile Gut, the more benefits you'll experience. With daily Fertile Gut goodness you will be optimising your microbiome for optimal health!
References
- Saei Ghare Naz, M., et al., The Effect of Micronutrients on Pain Management of Primary Dysmenorrhea: a Systematic Review and Meta-Analysis. J Caring Sci, 2020. 9 (1): p. 47-56
- Lerchbaum, E. and T. Rabe, Vitamin D and female fertility. Curr Opin Obstet Gynecol, 2014. 26 (3): p. 145-50.
- Rejnmark L, Vestergaard P, Hermann AP, Brot C, Eiken P, Mosekilde L. Dietary intake of folate, but not vitamin B2 or B12, is associated with increased bone mineral density 5 years after the menopause: results from a 10-year follow-up study in early postmenopausal women. Calcif Tissue Int. 2008 82(1):1-11
- Keller AC, Klawitter J, Hildreth KL, Christians U, Putnam K, Kohrt WM, Reusch JEB, Moreau KL. Elevated plasma homocysteine and cysteine are associated with endothelial dysfunction across menopausal stages in healthy women. J Appl Physiol (1985). 2019 126(6):1533-1540
- Chiu, T.T., et al., Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod, 2002. 17(6): p. 1591-6.
- Novielli, C., et al., Effects of alpha-lipoic acid and myo-inositol supplementation on the oocyte environment of infertile obese women: A preliminary study. Reprod Biol, 2020. 20(4): p. 541 - 546.
- Chan, K.Y., et al., Dietary supplementation for gestational diabetes prevention and management: a meta-analysis of randomized controlled trials. Arch Gynecol Obstet, 2021. 303(6): p. 1381-1391.
- Akbari Sene, A., et al., The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial. Arch Gynecol Obstet, 2019. 299(6): p. 1701-1707.
- Carlomagno, G., et al., Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use. Expert Opin Drug Deliv, 2012. 9(3): p. 267-71.
- Almassinokiani F, Kashanian M, Akbari P, Mossayebi E, Sadeghian E. Folic acid supplementation reduces plasma homocysteine in postmenopausal women. J Obstet Gynaecol. 2016 May;36(4):492-5.
- D'Anna, R., et al., Myoinositol plus alpha-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study. Sci Rep, 2021. 11(1): p. 8866.
- Dinkova, A., D. Martinov, and E. Konova, Efficacy of myo-inositol in the clinical management of patients with asthenozoospermia. Eur Rev Med Pharmacol Sci, 2017. 21(2 Suppl): p. 62-65.
- Dona, G., et al., Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome. Eur J Endocrinol, 2012. 166(4): p. 703-10.
- Genazzani, A.D., et al., Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome. J Obstet Gynaecol Res, 2014. 40(5): p. 1353-60.
- Ghasemi, A., et al., The effect of Myo-inositol on sperm parameters and pregnancy rate in oligoasthenospermic men treated with IUI: A randomized clinical trial. Int J Reprod Biomed, 2019. 17(10): p. 749-756.
- Korosi, T., et al., Physiological Intra-Cytoplasmic Sperm Injection (PICSI) outcomes after oral pretreatment and semen incubation with myo-inositol in oligoasthenoteratozoospermic men: results from a prospective, randomized controlled trial. Eur Rev Med Pharmacol Sci, 2017. 21(2 Suppl): p. 66-72.
- Lisi, F., et al., Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reprod Biol Endocrinol, 2012. 10: p. 52.
- Mashayekh-Amiri, S., et al., The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study. J Matern Fetal Neonatal Med, 2022. 35(18): p. 3415-3423.
- Papaleo, E., et al., Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril, 2009. 91(5): p. 1750-4.
- Rajasekaran, K., et al., Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study. Gynecol Endocrinol, 2021: p. 1-8.
- Showell, M.G., et al., Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev, 2018. 12: p. CD012378.
- Simi, G., et al., Inositol and In Vitro Fertilization with Embryo Transfer. Int J Endocrinol, 2017. 2017: p. 5469409.
- Unfer, V., et al., Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci, 2011. 15(4): p. 452-7.
- Unfer, V., et al., Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol, 2016. 2016: p. 1849162.
- Vazquez-Levin, M.H. and G.L. Veron, Myo-inositol in health and disease: its impact on semen parameters and male fertility. Andrology, 2020. 8(2): p. 277-298.
- Wdowiak, A., Myoinositol Improves Embryo Development in PCOS Patients Undergoing ICSI. Int J Endocrinol, 2016. 2016: p. 6273298.
- Zacche, M.M., et al., Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. Gynecol Endocrinol, 2009. 25(8): p. 508-13.
- Zhang, H., et al., The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med, 2019. 32(13): p. 2249-2255.
- Zheng, X., et al., Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. Medicine (Baltimore), 2017. 96(49): p. e8842.
- Jiang Caoa, et al., Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases. Journal of Functional Foods, 2020. 64.
- Majeed, M., et al., Comparative evaluation for thermostability and gastrointestinal survival of probiotic Bacillus coagulans MTCC 5856. Biosci Biotechnol Biochem, 2021. 85(4): p. 962-971.
- Mu, Y. and Y. Cong, Bacillus coagulans and its applications in medicine. Benef Microbes, 2019. 10(6): p. 679-688.
- Riazi, S., et al., Characterization of lactosporin, a novel antimicrobial protein produced by Bacillus coagulans ATCC 7050. J Appl Microbiol, 2009. 106(4): p. 1370-7.
- Aflatoonian, A., et al., Effect of vitamin D insufficiency treatment on fertility outcomes in frozen-thawed embryo transfer cycles: A randomized clinical trial. Iran J Reprod Med, 2014. 12(9): p. 595-600.
- Bertone-Johnson, E.R., et al., Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med, 2005. 165(11): p. 1246-52.
- Cunningham, T.K., et al., Association of Vitamin D Metabolites With Embryo Development and Fertilization in Women With and Without PCOS Undergoing Subfertility Treatment. Front Endocrinol (Lausanne), 2019. 10: p. 13.
- Dastorani, M., et al., The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Reprod Biol Endocrinol, 2018. 16(1): p. 94.
- Halloran, B.P. and H.F. DeLuca, Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J Nutr, 1980. 110(8): p. 1573-80.
- Hofer, D., et al., Testicular synthesis and vitamin D action. J Clin Endocrinol Metab, 2014. 99(10): p. 3766-73.
- Holick, M.F., The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord, 2017. 18(2): p. 153-165.
- Kwiecinski, G.G., G.I. Petrie, and H.F. DeLuca, Vitamin D is necessary for reproductive functions of the male rat. J Nutr, 1989. 119(5): p. 741-4.
- Macdonald, H.M., et al., Sunlight and dietary contributions to the seasonal vitamin D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? Osteoporos Int, 2011. 22(9): p. 2461-72.
- Merino, O., et al., Effect of high-fat and vitamin D deficient diet on rat sperm quality and fertility. Theriogenology, 2019. 125: p. 6-11.
- Ota, K., et al., Effects of MTHFR C677T polymorphism on vitamin D, homocysteine and natural killer cell cytotoxicity in women with recurrent pregnancy losses. Hum Reprod, 2020. 35(6): p. 1276-1287
- Pereira-Santos, M., et al., Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev, 2015. 16(4): p. 341-9.
- Rehman, R., et al., Association Between Vitamin D, Reproductive Hormones and Sperm Parameters in Infertile Male Subjects. Front Endocrinol (Lausanne), 2018. 9: p. 607.
- Rizzoli, R., Vitamin D supplementation: upper limit for safety revisited? Aging Clin Exp Res, 2021. 33(1): p. 19-24.
- Schaffler, H., et al., Vitamin D administration leads to a shift of the intestinal bacterial composition in Crohn's disease patients, but not in healthy controls. J Dig Dis, 2018. 19(4): p. 225-234.
- Singh, V., et al., Association between serum 25-hydroxy vitamin D level and menstrual cycle length and regularity: A cross-sectional observational study. Int J Reprod Biomed, 2021. 19(11): p. 979-986.
- Talsness, C.E., et al., Influence of vitamin D on key bacterial taxa in infant microbiota in the KOALA Birth Cohort Study. PLoS One, 2017. 12(11): p. e0188011.
- Thomson, R.L., S. Spedding, and J.D. Buckley, Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf), 2012. 77(3): p. 343-50.
- Waterhouse, M., et al., Vitamin D and the gut microbiome: a systematic review of in vivo studies. Eur J Nutr, 2019. 58(7): p. 2895-2910.
- Zhao, J., et al., Whether vitamin D was associated with clinical outcome after IVF/ICSI: a systematic review and meta-analysis. Reprod Biol Endocrinol, 2018. 16(1): p. 13.
- Zhao, J., et al., Vitamin D improves in-vitro fertilization outcomes in infertile women with polycystic ovary syndrome and insulin resistance. Minerva Med, 2019. 110(3): p. 199-208.
- Zhao, J.F., B.X. Li, and Q. Zhang, Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: a meta-analysis study. Ann Palliat Med, 2021. 10(1): p. 169-183.
- Ansell, J., et al., Kiwifruit-derived supplements increase stool frequency in healthy adults: a randomized, double-blind, placebo-controlled study. Nutr Res, 2015. 35(5): p. 401-8.
- Bayer, S.B., et al., Habitual Green Kiwifruit Consumption Is Associated with a Reduction in Upper Gastrointestinal Symptoms: A Systematic Scoping Review. Adv Nutr, 2022. 13(3): p. 846-856.
- Blatchford, P., et al., In vitro characterisation of the fermentation profile and prebiotic capacity of gold-fleshed kiwifruit. Benef Microbes, 2015. 6(6): p. 829-39.
- E, F.E.A., Ameliorative Effect of Kiwifruit (Actinidia deliciosa) against Lead-Induced Oxidative Stress in Wistar Albino Rats. Pak J Biol Sci, 2021. 24(5): p. 599-611.
- Iwasawa, H., et al., Anti-oxidant effects of kiwi fruit in vitro and in vivo. Biol Pharm Bull, 2011. 34(1): p. 128-34.
- Kruger, M.C., et al., The effects of green kiwifruit combined with isoflavones on equol production, bone turnover and gut microflora in healthy postmenopausal women. Asia Pac J Clin Nutr, 2018. 27(2): p. 347-358.
- Lee, Y.K., et al., Kiwifruit (Actinidia deliciosa) changes intestinal microbial profile. Microbial ecology in health and disease, 2012. 23: p. 10.3402/mehd.v23i0.18572.
- Lee, Y.K., et al., Kiwifruit (Actinidia deliciosa) changes intestinal microbial profile. Microb Ecol Health Dis, 2012. 23
- Parkar, S.G., et al., In vitro utilization of gold and green kiwifruit oligosaccharides by human gut microbial populations. Plant Foods Hum Nutr, 2012. 67(3): p. 200-7.
- Richardson, D.P., J. Ansell, and L.N. Drummond, The nutritional and health attributes of kiwifruit: a review. Eur J Nutr, 2018. 57(8): p. 2659-2676.
- Wang, K., et al., Insoluble and Soluble Dietary Fibers from Kiwifruit (Actinidia deliciosa) Modify Gut Microbiota to Alleviate High-Fat Diet and Streptozotocin-Induced TYPE 2 Diabetes in Rats. Nutrients, 2022. 14(16).
- Yuan, M., et al., Supplementation of Kiwifruit Polyphenol Extract Attenuates High Fat Diet Induced Intestinal Barrier Damage and Inflammation via Reshaping Gut Microbiome. Front Nutr, 2021. 8: p. 702157.